Grassley rejects credibility of industry pledge to save costs
This article was originally published in Clinica
Executive Summary
US Senator Charles Grassley, one of the medtech industry’s most vocal and powerful critics, continued to dig the knife in this week, this time disparaging a promise from big businesses to help cut healthcare costs.